Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Change in Accured Expenses (2017 - 2025)

Inspire Medical Systems' Change in Accured Expenses history spans 9 years, with the latest figure at $6.6 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 51.44% year-over-year to $6.6 million; the TTM value through Dec 2025 reached $6.1 million, down 52.41%, while the annual FY2025 figure was $6.1 million, 52.41% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was $6.6 million at Inspire Medical Systems, down from $10.8 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $13.7 million in Q4 2024 and bottomed at -$16.3 million in Q1 2025.
  • The 5-year median for Change in Accured Expenses is $4.4 million (2022), against an average of $2.2 million.
  • The largest annual shift saw Change in Accured Expenses soared 6562.86% in 2021 before it plummeted 126.99% in 2022.
  • A 5-year view of Change in Accured Expenses shows it stood at $2.8 million in 2021, then surged by 73.57% to $4.9 million in 2022, then soared by 105.35% to $10.1 million in 2023, then surged by 35.38% to $13.7 million in 2024, then tumbled by 51.44% to $6.6 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Change in Accured Expenses are $6.6 million (Q4 2025), $10.8 million (Q3 2025), and $5.0 million (Q2 2025).